Discover the newest research about AI innovations in π§ͺ Drug Discovery.
Machine learning reveals 11 hub biomarkers for coronary artery disease, highlighting ITM2B’s potential role in inflammation. π«π¬
Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. ππ€
Deep learning enhances sonosensitizer-drug co-assembly, achieving 90% precision and 96% recall for cancer therapy. π‘π¬
Klebsiella pneumoniae’s rising virulence and antibiotic resistance pose significant health risks. π¦ π Explore novel therapeutic strategies!
South Korea’s government supports medtech firms with a new tariff center to address trade challenges. π°π·π
New AI method improves insights into cellular responses to drug treatments. π§¬π Researchers aim to enhance medical research and therapies.
Healthcare AI adoption is rising, with 70% of providers implementing technologies. However, data integration issues remain a challenge. ππ€
BioStruct-Africa’s workshops enhance structural biology skills in Africa, utilizing AI tools like AlphaFold for disease research. ππ¬
Pharmacogenomics enhances drug therapy for rare diseases, optimizing treatment and minimizing adverse reactions. AI tools play a crucial role. π§¬π
New AI Tool Enhances Drug Development for Disease Treatment π§¬π
A new AI tool, LogiRx, accelerates drug development by predicting effects on biological processes, aiding in heart disease treatment.
